Combinational strategy for high-performance cancer chemotherapy

Combinational therapy, including combination chemotherapy, chemotherapy plus gene therapy, chemotherapy plus phototherapy, chemotherapy plus immunotherapy, as well as chemotherapy-involved multiple therapy, are confirmed to be the robust choices for high-performance cancer chemotherapy due to their abilities of conquering tumor heterogeneity and complexity, reversing multidrug resistance (MDR), and decreasing unwanted side effects, etc.64